These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


137 related items for PubMed ID: 3777620

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Protective effect of exogenous fructose-1,6-diphosphate in cardiogenic shock.
    Zhang JN, Zhang FM, Ma WS, Forrester T.
    Cardiovasc Res; 1988 Dec; 22(12):927-32. PubMed ID: 3256432
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Metabolic effects of fructose diphosphate in hypoxic and ischemic states.
    Webb WR.
    J Thorac Cardiovasc Surg; 1984 Nov; 88(5 Pt 2):863-6. PubMed ID: 6238213
    [Abstract] [Full Text] [Related]

  • 9. Improved exercise tolerance by i.v. fructose-1,6-diphosphate in chronic, stable angina pectoris.
    Marchionni N, Moschi G, Di Bari M, Ferrucci L, Paoletti M, Salani B, Fattirolli F.
    J Clin Pharmacol; 1988 Sep; 28(9):807-11. PubMed ID: 3230148
    [Abstract] [Full Text] [Related]

  • 10. Myocardial protection using fructose-1,6-diphosphate during coronary artery bypass graft surgery: a randomized, placebo-controlled clinical trial.
    Riedel BJ, Gal J, Ellis G, Marangos PJ, Fox AW, Royston D.
    Anesth Analg; 2004 Jan; 98(1):20-29. PubMed ID: 14693576
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Fructose-1,6-diphosphate: an agent for treatment of experimental endotoxin shock.
    Markov AK, Turner MD, Oglethorpe N, Neely WA, Hellems HK.
    Surgery; 1981 Sep; 90(3):482-8. PubMed ID: 6455765
    [No Abstract] [Full Text] [Related]

  • 16. Inability of fructose 1,6-diphosphate to reduce myocardial infarct size.
    Brown EJ, Erburu L, Kloner RA.
    J Med; 1987 Sep; 18(1):43-53. PubMed ID: 3474341
    [Abstract] [Full Text] [Related]

  • 17. Successful treatment of irreversible hemorrhagic shock in dogs with fructose-1,6 diphosphate and dichloroacetate.
    Granot H, Steiner I.
    Circ Shock; 1985 Sep; 15(3):163-73. PubMed ID: 3978767
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of fructose 1,6 diphosphate for salvage of ischemic gracilis flaps in rats.
    Sud V, Lindley SG, McDaniel O, Freeland AE, Zhang F, Dorsett-Martin W, Bigler SA, Lineaweaver W.
    J Reconstr Microsurg; 2005 Apr; 21(3):191-6. PubMed ID: 15880299
    [Abstract] [Full Text] [Related]

  • 19. Fructose 1,6-diphosphate administration attenuates post-ischemic ventricular dysfunction.
    Cohen JE, Atluri P, Taylor MD, Grand TJ, Liao GP, Panlilio CM, Suarez EE, Zentko SE, Hsu VM, Berry MF, Smith MJ, Gardner TJ, Sweeney HL, Woo YJ.
    Heart Lung Circ; 2006 Apr; 15(2):119-23. PubMed ID: 16469539
    [Abstract] [Full Text] [Related]

  • 20. Fructose-1,6-diphosphate attenuates acute lung injury induced by ischemia-reperfusion in rats.
    Chu SJ, Chang DM, Wang D, Chen YH, Hsu CW, Hsu K.
    Crit Care Med; 2002 Jul; 30(7):1605-9. PubMed ID: 12130986
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.